504 related articles for article (PubMed ID: 31647978)
1. Recent advances on thermosensitive and pH-sensitive liposomes employed in controlled release.
Abri Aghdam M; Bagheri R; Mosafer J; Baradaran B; Hashemzaei M; Baghbanzadeh A; de la Guardia M; Mokhtarzadeh A
J Control Release; 2019 Dec; 315():1-22. PubMed ID: 31647978
[TBL] [Abstract][Full Text] [Related]
2. Light induced cytosolic drug delivery from liposomes with gold nanoparticles.
Lajunen T; Viitala L; Kontturi LS; Laaksonen T; Liang H; Vuorimaa-Laukkanen E; Viitala T; Le Guével X; Yliperttula M; Murtomäki L; Urtti A
J Control Release; 2015 Apr; 203():85-98. PubMed ID: 25701610
[TBL] [Abstract][Full Text] [Related]
3. Stimuli-responsive liposomal nanoformulations in cancer therapy: Pre-clinical & clinical approaches.
Ashrafizadeh M; Delfi M; Zarrabi A; Bigham A; Sharifi E; Rabiee N; Paiva-Santos AC; Kumar AP; Tan SC; Hushmandi K; Ren J; Zare EN; Makvandi P
J Control Release; 2022 Nov; 351():50-80. PubMed ID: 35934254
[TBL] [Abstract][Full Text] [Related]
4. State of the Art of Stimuli-Responsive Liposomes for Cancer Therapy.
Heidarli E; Dadashzadeh S; Haeri A
Iran J Pharm Res; 2017; 16(4):1273-1304. PubMed ID: 29552041
[TBL] [Abstract][Full Text] [Related]
5. Stimuli-responsive liposomes for drug delivery.
Lee Y; Thompson DH
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2017 Sep; 9(5):. PubMed ID: 28198148
[TBL] [Abstract][Full Text] [Related]
6. Recent Advancements of Stimuli-Responsive Targeted Liposomal Formulations for Cancer Drug Delivery.
Alrbyawi H; Poudel I; Annaji M; Arnold RD; Tiwari AK; Babu RJ
Pharm Nanotechnol; 2022; 10(1):3-23. PubMed ID: 35156590
[TBL] [Abstract][Full Text] [Related]
7. A novel tumor-targeted thermosensitive liposomal cerasome used for thermally controlled drug release.
Li S; Yin G; Pu X; Huang Z; Liao X; Chen X
Int J Pharm; 2019 Oct; 570():118660. PubMed ID: 31491484
[TBL] [Abstract][Full Text] [Related]
8. Classification of stimuli-responsive polymers as anticancer drug delivery systems.
Taghizadeh B; Taranejoo S; Monemian SA; Salehi Moghaddam Z; Daliri K; Derakhshankhah H; Derakhshani Z
Drug Deliv; 2015 Feb; 22(2):145-55. PubMed ID: 24547737
[TBL] [Abstract][Full Text] [Related]
9. Influence of polymer size, liposomal composition, surface charge, and temperature on the permeability of pH-sensitive liposomes containing lipid-anchored poly(2-ethylacrylic acid).
Lu T; Wang Z; Ma Y; Zhang Y; Chen T
Int J Nanomedicine; 2012; 7():4917-26. PubMed ID: 23028220
[TBL] [Abstract][Full Text] [Related]
10. Recent advances on liposomal nanoparticles: synthesis, characterization and biomedical applications.
Panahi Y; Farshbaf M; Mohammadhosseini M; Mirahadi M; Khalilov R; Saghfi S; Akbarzadeh A
Artif Cells Nanomed Biotechnol; 2017 Jun; 45(4):788-799. PubMed ID: 28278586
[TBL] [Abstract][Full Text] [Related]
11. Liposomal Doxorubicin Delivery Systems: Effects of Formulation and Processing Parameters on Drug Loading and Release Behavior.
Mohammadi ZA; Aghamiri SF; Zarrabi A; Talaie MR
Curr Drug Deliv; 2016; 13(7):1065-1070. PubMed ID: 26708673
[TBL] [Abstract][Full Text] [Related]
12. pH-Responsive Polymer Nanoparticles for Drug Delivery.
Deirram N; Zhang C; Kermaniyan SS; Johnston APR; Such GK
Macromol Rapid Commun; 2019 May; 40(10):e1800917. PubMed ID: 30835923
[TBL] [Abstract][Full Text] [Related]
13. Thermo-responsive systems for controlled drug delivery.
Bikram M; West JL
Expert Opin Drug Deliv; 2008 Oct; 5(10):1077-91. PubMed ID: 18817514
[TBL] [Abstract][Full Text] [Related]
14. Dual and multi-stimuli responsive polymeric nanoparticles for programmed site-specific drug delivery.
Cheng R; Meng F; Deng C; Klok HA; Zhong Z
Biomaterials; 2013 May; 34(14):3647-57. PubMed ID: 23415642
[TBL] [Abstract][Full Text] [Related]
15. A novel kinetic model to describe the ultra-fast triggered release of thermosensitive liposomal drug delivery systems.
Lu T; Ten Hagen TLM
J Control Release; 2020 Aug; 324():669-678. PubMed ID: 32512013
[TBL] [Abstract][Full Text] [Related]
16. Recent advances in liposomal nanohybrid cerasomes as promising drug nanocarriers.
Yue X; Dai Z
Adv Colloid Interface Sci; 2014 May; 207():32-42. PubMed ID: 24368133
[TBL] [Abstract][Full Text] [Related]
17. pH-responsive chimeric liposomes: From nanotechnology to biological assessment.
Naziris N; Saitta F; Chrysostomou V; Libera M; Trzebicka B; Fessas D; Pispas S; Demetzos C
Int J Pharm; 2020 Jan; 574():118849. PubMed ID: 31759108
[TBL] [Abstract][Full Text] [Related]
18. NGR-modified pH-sensitive liposomes for controlled release and tumor target delivery of docetaxel.
Gu Z; Chang M; Fan Y; Shi Y; Lin G
Colloids Surf B Biointerfaces; 2017 Dec; 160():395-405. PubMed ID: 28965079
[TBL] [Abstract][Full Text] [Related]
19. pH-sensitive liposomes for drug delivery in cancer treatment.
Ferreira Ddos S; Lopes SC; Franco MS; Oliveira MC
Ther Deliv; 2013 Sep; 4(9):1099-123. PubMed ID: 24024511
[TBL] [Abstract][Full Text] [Related]
20. Thermosensitive liposomal drug delivery systems: state of the art review.
Kneidl B; Peller M; Winter G; Lindner LH; Hossann M
Int J Nanomedicine; 2014; 9():4387-98. PubMed ID: 25258529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
